Beauty Farm Medical and Health Industry Inc. on 25 June 2026 reported the repurchase of 40,000 ordinary shares on the Hong Kong Stock Exchange, paying an aggregate HKD 0.66 million. The shares were bought at prices ranging from HKD 16.48 to HKD 16.73, translating into a volume-weighted average cost of HKD 16.58 per share.

Following the transaction, the company’s issued share capital (excluding treasury shares) declined from 248.56 million to 248.52 million, while treasury shares increased to 3.07 million. The 40,000-share reduction represents 0.0161% of the pre-transaction free float. Total shares in issue, including treasury stock, remain unchanged at 251.59 million.

The buyback forms part of the repurchase mandate approved by shareholders on 27 June 2025, which authorises the company to acquire up to 23.58 million shares. Cumulative repurchases under this mandate now stand at 3.07 million shares, equivalent to 1.30% of the share count at the mandate date. In line with Hong Kong listing rules, Beauty Farm Medical is restricted from issuing new shares or disposing of treasury shares until 25 July 2026.